JP2002544200A - １，５−ベンゾジアゼピン誘導体 - Google Patents

１，５−ベンゾジアゼピン誘導体

Info

Publication number
JP2002544200A
JP2002544200A JP2000617189A JP2000617189A JP2002544200A JP 2002544200 A JP2002544200 A JP 2002544200A JP 2000617189 A JP2000617189 A JP 2000617189A JP 2000617189 A JP2000617189 A JP 2000617189A JP 2002544200 A JP2002544200 A JP 2002544200A
Authority
JP
Japan
Prior art keywords
cck
compound
enantiomer
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000617189A
Other languages
English (en)
Japanese (ja)
Inventor
デビッド、コルクラフ
アン、ホッジソン
ジャージー、リザード、セウクジック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JP2002544200A publication Critical patent/JP2002544200A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2000617189A 1999-05-06 2000-05-04 １，５−ベンゾジアゼピン誘導体 Pending JP2002544200A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9910366.5 1999-05-06
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GB0008179.4 2000-04-05
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process
PCT/EP2000/003982 WO2000068209A2 (fr) 1999-05-06 2000-05-04 Derives de 1,5-benzodiazepines

Publications (1)

Publication Number Publication Date
JP2002544200A true JP2002544200A (ja) 2002-12-24

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000617189A Pending JP2002544200A (ja) 1999-05-06 2000-05-04 １，５−ベンゾジアゼピン誘導体

Country Status (21)

Country Link
EP (1) EP1212305A2 (fr)
JP (1) JP2002544200A (fr)
KR (1) KR20020012567A (fr)
CN (1) CN1161345C (fr)
AR (1) AR022044A1 (fr)
AU (1) AU4754800A (fr)
BR (1) BR0010338A (fr)
CA (1) CA2370801A1 (fr)
CO (1) CO5170461A1 (fr)
CZ (1) CZ20013988A3 (fr)
HK (1) HK1046138A1 (fr)
HU (1) HUP0201181A3 (fr)
IL (1) IL146124A0 (fr)
MX (1) MXPA01011267A (fr)
MY (1) MY138319A (fr)
NO (1) NO20015397D0 (fr)
NZ (1) NZ515048A (fr)
PE (1) PE20010110A1 (fr)
PL (1) PL351546A1 (fr)
TR (1) TR200103169T2 (fr)
WO (1) WO2000068209A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (fr) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Marqueurs et haplotypes de cckar associes a des etats d'excedent de poids
JP4069159B2 (ja) 2004-05-25 2008-04-02 ファイザー・プロダクツ・インク テトラアザベンゾ［ｅ］アズレン誘導体及びそれらのアナログ
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
CN1161345C (zh) 2004-08-11
KR20020012567A (ko) 2002-02-16
WO2000068209A3 (fr) 2001-03-01
TR200103169T2 (tr) 2002-04-22
PE20010110A1 (es) 2001-03-05
BR0010338A (pt) 2002-02-13
IL146124A0 (en) 2002-07-25
EP1212305A2 (fr) 2002-06-12
NO20015397L (no) 2001-11-05
HUP0201181A2 (hu) 2002-12-28
CZ20013988A3 (cs) 2002-02-13
AR022044A1 (es) 2002-09-04
CN1362949A (zh) 2002-08-07
HUP0201181A3 (en) 2003-10-28
PL351546A1 (en) 2003-05-05
NO20015397D0 (no) 2001-11-05
MXPA01011267A (es) 2002-05-06
MY138319A (en) 2009-05-29
AU4754800A (en) 2000-11-21
NZ515048A (en) 2004-01-30
HK1046138A1 (zh) 2002-12-27
CO5170461A1 (es) 2002-06-27
WO2000068209A2 (fr) 2000-11-16
CA2370801A1 (fr) 2000-11-16

Similar Documents

Publication Publication Date Title
JP3406317B2 (ja) Ｃｃｋアンタゴニストまたはアゴニスト作用を有する１，５−ベンゾジアゼピン誘導体
US4820834A (en) Benzodiazepine analogs
US5220017A (en) Cholecystokinin antagonists
US7271162B2 (en) Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
US7271164B2 (en) Cyclohepta[b][1,4]diazepino[6,7,1,-hi]indoles and derivatives
US5302591A (en) Benzodiazepine derivatives
RU2175323C2 (ru) N-триазолил-2-индолкарбоксамиды, способ их получения (варианты), содержащая их фармацевтическая композиция (варианты) и 1-замещенные 3-аминотриазолы
EP0667344A1 (fr) 3-acylamino-5-(phényl polysubstitué)-1,4-benzodiazépin-2-ones utiles comme abonistes du récepteur CCK
US5218114A (en) Cholecystokinin antagonists
KR100347287B1 (ko) 콜레시스토키닌또는가스트린의길항물질로서유용한1,5-벤조디아제핀유도체
AU742498B2 (en) 1,5-benzodiazepine derivatives
JP3922024B2 (ja) １，５−ベンゾジアゼピン誘導体カルシウム塩及びその製造法並びに該化合物を有効成分とする医薬
HUT76135A (en) Cholecystokinin and gastrin modulating 5-heterocyclic-1,5-benzodiazepines
JPH08509237A (ja) ガストリンまたはｃｃｋ拮抗剤として有用な１，５‐ベンゾジアゼピン類
JP2002544200A (ja) １，５−ベンゾジアゼピン誘導体
US5399565A (en) Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
AU688316B2 (en) 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
JPH10511931A (ja) 非インシュリン依存性糖尿病の患者において胃空腹を抑制する１，５−ベンゾジアゼピン誘導体の使用
ZA200108827B (en) 1,5-Benzodiazepine derivatives as CCK-A receptor agonists.
JPH10511930A (ja) Ｃｃｋアンタゴニスト活性またはアゴニスト活性を有する１，５−ベンゾジアゼピン誘導体を含んでなる腸溶性コーティング組成物
AU2004201385A1 (en) 1,5-benzodiazepine derivatives
US5206238A (en) Cholecystokinin antagonists
EP0486271A2 (fr) Antagonistes de la cholecystokinine pour le traitement de troubles neurologiques
JPH0741476A (ja) ベンゾジアゼピン誘導体